Our Work
Data and data analyses live at the heart of drug discovery programs, from target identification to indication selection, aiding in investigation of in vitro and in vivo models, development of MoA hypotheses, and population segmentation for clinical trials. Below, find some ways in which Sprout Informatics has leveraged a variety of data and analytical approaches to drive programs forward.
Case Study 1
Mining over 400,000 public RNA sequencing datasets to identify poison exons and building a deep learning framework to predict the best candidates for drug target screening.
Read moreCase Study 2
Mining over 36,000 samples spanning common and rare cancers to identify indications with the greatest differential gene expression and build interactive dashboards for target profiling.
Read moreCase Study 3
Leveraging external public data to uncover the mechanism of action for unknown chemical matter by analyzing transcriptomic fingerprints and overlaying them on known pathway networks.
Read moreCase Study 4
A large-scale meta-analysis of bulk and single-cell RNA-seq data showing how Siglec-15 and PD-L1 co-expression varies across cancer indications, informing combination immunotherapy strategies.
Read moreCase Study 5
Creating a novel algorithm and pipeline for pseudo-bulk isoform-level quantification at the single-cell level to identify cell types producing target proteins.
Read moreCase Study 6
Building a best-in-class bacterial classification pipeline that enabled unprecedented resolution for the first FDA-approved oral microbiome therapeutic.
Read more